Showing results (681-690 of 1,412) with videos related to

Sort By:
Pageof 142
BMC Cancer|October 18, 2005
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapyL Lim, P Gibbs, D Yip, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2008
Clarithromycin prevents smoke-induced emphysema in miceYutaka Nakanishi, Dale Kobayashi, Yasuo Asano, et al.
American Journal of Preventive Cardiology|August 14, 2023
Association between physical activity and clinical outcomes in high-risk hypertension: Post-hoc analysis of SPRINTRichard Kazibwe, Matthew J Singleton, Parag A Chevli, et al.
American Journal of Preventive Cardiology|October 6, 2025
Relationship between interleukin-6, coronary artery calcium and risk of heart failure: Insights from MESAMuhammad Imtiaz Ahmad, Parag A Chevli, Saeid Mirzai, et al.
Human Genetics|January 1, 1983
Clinical heterogeneity in the tricho-dento-osseous syndromeF Quattromani, S D Shapiro, R S Young, et al.
Internal Medicine Journal|April 20, 2005
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignanciesL Lim, P Gibbs, D Yip, et al.
Medicine and Science in Sports and Exercise|December 30, 2021
Physical Activity, Coronary Artery Calcium, and Cardiovascular Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA)Charles A German, Jason Fanning, Matthew J Singleton, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|September 23, 2018
Adverse birth outcomes and infant mortality according to registered First Nations status and First Nations community residence across CanadaGabriel D Shapiro, Amanda J Sheppard, Tracey Bushnik, et al.
Journal of Dermatological Science|April 1, 1993
Labeling of fractured human skin with antibodies to BM 600/nicein, epiligrin, kalinin and other matrix componentsE Ceilley, N Watanabe, D Shapiro, et al.
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia BAmy D Shapiro, K John Pasi, Margareth C Ozelo, et al.
Pageof 142